Abstract
Acoustic simulations of cochlear implants (CIs) allow for studies of perceptual performance with minimized effects of large CI individual variability. Different from conventional simulations using continuous sinusoidal or noise carriers, the present study employs pulsatile Gaussian-enveloped tones (GETs) to simulate several key features in modern CIs. Subject to the time-frequency uncertainty principle, the GET has a well-defined tradeoff between its duration and bandwidth. Two types of GET vocoders were implemented and evaluated in normal-hearing listeners. In the first implementation, constant 100-Hz GETs were used to minimize within-channel temporal overlap while different GET durations were used to simulate electric channel interaction. This GET vocoder could produce vowel and consonant recognition similar to actual CI performance. In the second implementation, 900-Hz/channel pulse trains were directly mapped to 900-Hz GET trains to simulate the maxima selection and amplitude compression of a widely-used n-of-m processing strategy, or the Advanced Combination Encoder. The simulated and actual implant performance of speech-in-noise recognition was similar in terms of the overall trend, absolute mean scores, and standard deviations. The present results suggest that the pulsatile GET vocoders can be used as alternative vocoders to simultaneously simulate several key CI processing features and result in similar speech perception performance to that with modern CIs.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This research was supported by NIH R01 DC15587 (F.G.Z.), National Natural Science Foundation of China (11704129 and 61771320), Guangdong Basic and Applied Basic Research Foundation Grant (2020A1515010386), and Science and Technology Program of Guangzhou (202102020944) (Q.M.).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
University of California Irvine Institutional Review Board and Medical Ethics Committee of Shenzhen University gave ethical approval for this work.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
This research was supported by NIH R01 DC15587 (F.G.Z.), National Natural Science Foundation of China (11704129 and 61771320), Guangdong Basic and Applied Basic Research Foundation Grant (2020A1515010386), and Science and Technology Program of Guangzhou (202102020944) (Q.M.).
(e-mail: mengqinglin{at}scut.edu.cn)
(e-mail: zhouhuali2021{at}email.szu.edu.cn)
(e-mail: Luthomas556{at}gmail.com; fzeng{at}uci.edu)
Minor revisions have been made to improve the clarity.
Data Availability
All data produced in the present study are available upon reasonable request to the authors
